01 4Xiidra
Main Therapeutic Indication : Ophthalmology
Currency : USD
2020 Revenue in Millions : 376
2019 Revenue in Millions : 192
Growth (%) : 96
Main Therapeutic Indication : Ophthalmology
Currency : USD
2021 Revenue in Millions : 468
2020 Revenue in Millions : 376
Growth (%) : 24
Main Therapeutic Indication : Ophthalmology
Currency : USD
2022 Revenue in Millions : 487
2021 Revenue in Millions : 468
Growth (%) : 4
Main Therapeutic Indication : Ophthalmology
Currency : USD
2019 Revenue in Millions : 192
2018 Revenue in Millions : 0
Growth (%) : N/A
LOOKING FOR A SUPPLIER?
